KCM
NVNO

Kingdon Capital Management’s enVVeno Medical NVNO Stock Holding History

Kingdon Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$366K Sell
36,166
-1
-0% -$11 0.04% 67
2025
Q4 		$406K Sell
36,167
-2,669
-7% -$51.9K 0.05% 68
2025
Q3 		$1.23M Buy
38,836
+14,286
+58% +$1.46M 0.15% 73
2025
Q2 		$3.43M Hold
24,550
– – 0.46% 58
2025
Q1 		$2.26M Hold
24,550
– – 0.24% 60
2024
Q4 		$2.59M Hold
24,550
– – 0.37% 62
2024
Q3 		$2.89M Buy
24,550
+5,868
+31% +$1.08M 0.32% 70
2024
Q2 		$3.43M Hold
18,682
– – 0.37% 70
2024
Q1 		$3.56M Buy
18,682
+991
+6% +$178K 0.39% 75
2023
Q4 		$3.18M Buy
17,691
+11,429
+183% +$1.82M 0.4% 64
2023
Q3 		$1.18M Hold
6,262
– – 0.14% 70
2023
Q2 		$675K Hold
6,262
– – 0.06% 78
2023
Q1 		$1.03M Hold
6,262
– – 0.19% 52
2022
Q4 		$1.12M Hold
6,262
– – 0.22% 46
2022
Q3 		$1.38M Hold
6,262
– – 0.18% 52
2022
Q2 		$829K Hold
6,262
– – 0.14% 65
2022
Q1 		$1.4M Hold
6,262
– – 0.15% 75
2021
Q4 		$1.44M Buy
+6,262
New +$1.76M 0.17% 71

Other funds holding NVNO

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kingdon Capital Management's NVNO Position: Q1 2026 in Review

Kingdon Capital Management reduced its enVVeno Medical (NVNO) stake by 0% in Q1 2026, selling an estimated $11 and leaving 36,166 shares worth $366K. The position accounts for 0.04% of the portfolio, ranked #67.

Kingdon Capital Management first reported a position in NVNO in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.56M in Q1 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Kingdon Capital Management held 36,166 shares of enVVeno Medical worth $366K as of Q1 2026.
  • Kingdon Capital Management sold 1 enVVeno Medical share in Q1 2026, an estimated $11.
  • enVVeno Medical made up 0.04% of Kingdon Capital Management's portfolio in Q1 2026, its #67 holding.
  • Kingdon Capital Management first reported a position in enVVeno Medical in Q4 2021 and has held it in 18 quarters since.
  • Kingdon Capital Management's enVVeno Medical position peaked at $3.56M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Kingdon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.